update deskU.S.-Israel Relations

Bipartisan House bill supports stronger US-Israel healthcare ties

“At a time when Israel is under attack, it is critical that potential medical breakthroughs are not stifled,” said Rep. Mariannette Miller-Meeks.

Credit: Konstantin Kolosov/Pixabay.
Credit: Konstantin Kolosov/Pixabay.

A new House bill, which goes by the “MIRACLE” Medical Technology Act—for “maximizing Israel-U.S. research advancement and collaborative leadership in emerging” medical tech—aims to strengthen U.S. and Israeli healthcare ties.

“Similar to the United States, Israel is a leading hub for new and innovative health-related technology,” said Rep. Vern Buchanan (R-Fla.), who introduced the bill.

The congressman led the bipartisan legislation with Rep. Mariannette Miller-Meeks (R-Iowa) and Rep. Darren Soto (D-Fla.) “to help foster and build stronger ties in health care between the United States and our greatest ally in the Middle East, Israel,” he said.

The bill promotes U.S. and Israeli research and development, “innovation hubs to accelerate the development and commercialization of new and emerging health technologies” and protects health intellectual property for biologicals that the two nations share.

It also addresses hospital cybersecurity, telemedicine infrastructure, programs to prevent diseases and training, and establishes a “U.S. Israel Health Care Collaboration Center,” per Buchanan’s office.

“At a time when Israel is under attack, it is critical that potential medical breakthroughs are not stifled,” Miller-Meeks said.

Soto said that as a world leader, Washington must “welcome opportunities to improve our development of medical devices, pharmaceuticals and other solutions such as early-stage clinical trials.”

AIPAC, the Combat Antisemitism Movement, the Conference of Presidents of Major American Jewish Organizations and the Jewish Federations of North America supported the legislation.

You have read 3 articles this month.
Register to receive full access to JNS.

Just before you scroll on...

Israel is at war.

JNS is combating the stream of misinformation on Israel with real, honest and factual reporting. In order to deliver this in-depth, unbiased coverage of Israel and the Jewish world, we rely on readers like you.

The support you provide allows our journalists to deliver the truth, free from bias and hidden agendas. Can we count on your support?

Every contribution, big or small, helps JNS.org remain a trusted source of news you can rely on.

Become a part of our mission by donating today
Thank you. You are a loyal JNS Reader.
You have read more than 10 articles this month.
Please register for full access to continue reading and post comments.
Never miss a thing
Get the best stories faster with JNS breaking news updates